Protein kinase A activity is associated with metacyclogenesis in Leishmania amazonensis

Marcelo Genestra1, Léa Cysne-Finkelstein, Leonor Leon

  • 1Department of Immunology, Oswaldo Cruz Institute, 21045-900 Rio de Janeiro, RJ, Brazil. genestra@ioc.fiocruz.br

Insights

Protein kinase A (PKA) activity in Leishmania amazonensis is higher in infective promastigotes, suggesting a role in metacyclogenesis. This PKA may be a target for new leishmanicidal drugs.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Biochemistry

Background:

  • Cell signaling pathways, including adenylate cyclase/protein kinase A (PKA), are crucial for parasite proliferation and differentiation.
  • Leishmania amazonensis, a protozoan parasite, relies on complex signaling for its life cycle stages.

Purpose of the Study:

  • To investigate the role and activity of protein kinase A (PKA) in different life cycle stages of Leishmania amazonensis.
  • To explore the potential of PKA as a drug target for leishmaniasis.

Main Methods:

  • Assaying PKA activity in soluble (SF) and membrane fractions (MF) of promastigotes and axenic amastigotes.
  • Chromatographic purification of PKA using DEAE-cellulose columns.
  • Evaluating phosphorylative activity using [gamma(32)P]-ATP in the presence of cyclic adenosine monophosphate (cAMP) and a PKA inhibitor.

Main Results:

  • PKA activity was significantly higher (approximately twofold) in SF from infective promastigotes (metacyclic forms) compared to non-infective promastigotes.
  • A lower level of phosphorylative activity was detected in axenic amastigotes.
  • The findings suggest a correlation between PKA activity and the metacyclogenesis process.

Conclusions:

  • PKA activity is associated with the metacyclogenesis stage in Leishmania amazonensis.
  • The adenylate cyclase/cAMP pathway, and specifically PKA, may play a role in parasite-host interactions.
  • Leishmania amazonensis PKA represents a potential intracellular target for the development of novel leishmanicidal drugs.

Related Concept Videos

Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...